NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy
Christian Rønn Hansen, Jeppe Friborg, Kenneth Jensen et al. · Acta Oncologica · 2019
Introduction: Prediction models using logistic regression may perform poorly in external patient cohorts. However, there is a need to standardize and validate models for clinical use. The purpose of this project was to describe a method for validation of external NTCP models used for patient selection in the randomized trial of protons versus photons in head and neck cancer radiotherapy, DAHANCA 35.Material and methods: Organs at risk of 588 patients treated primarily with IMRT in the randomized controlled DAHANCA19 trial were retrospectively contoured according to recent international recommendations. Dose metrics were extracted using MatLab and all clinical parameters were retrieved from the DAHANCA database. The model proposed by Christianen et al. to predict physician-rated dysphagia was validated through the closed testing, where change of the model intercept, slope and individual beta’s were tested for significant prediction improvements.Results: Six months prevalence of dysphagia in the validation cohort was 33%. The closed testing procedure for physician-rated dysphagia showed that the Christianen et al. model needed an intercept refitting for the best match for the Danish patients. The intercept update increased the risk of dysphagia for the validation cohort by 7.9 ± 2.5% point. For the raw model performance, the Brier score (mean squared residual) was 0.467, which improved significantly with a new intercept to 0.415.Conclusions: The previously published Dutch dysphagia model needed an intercept update to match the Danish patient cohort. The implementation of a closed testing procedure on the current validation cohort allows quick and efficient validation of external NTCP models for patient selection in the future.
Cited by 41 works. doi:10.1080/0284186x.2019.1654129 Open-access PDF
Authors
- Christian Rønn Hansen
- Jeppe Friborg
- Kenneth Jensen
- Eva Samsøe
- L. Johnsen
- Ruta Zukauskaite
- Cai Grau
- Christian Maare
- Jørgen Johansen
- Hanne Primdahl
- Åse Bratland
- Claus Andrup Kristensen
- Maria Andersen
- Jesper Grau Eriksen
- Jens Overgaard
References
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
- Use of Normal Tissue Complication Probability Models in the Clinic
- CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach
- ‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’
- Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study
- A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer
- The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires
- NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors
- Improving Normal Tissue Complication Probability Models: The Need to Adopt a “Data-Pooling” Culture